FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) in Pennsylvania
Doctor-prescribed FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) for Pennsylvania residents. Reviewed by licensed Pennsylvania physicians, compounded at FDA-registered pharmacies, and shipped to your door.

— All-in monthly price
No membership fee · this is the full price · free shipping · avg 4-week supply
— Add in-depth bloodwork
Optional — add a physician-reviewed at-home blood panel to your plan.
Your sex-hormone baseline plus the safety markers that matter on therapy — blood counts, liver and kidney function — from one painless upper-arm device. Matched to your sex (PSA for men; progesterone & FSH for women). No needle, no clinic, physician-reviewed.
This treatment requires licensed provider review and approval. Treatment is not guaranteed. If prescribed, medication is fulfilled by a licensed U.S. pharmacy where permitted by law. Compounded medications are not FDA-approved or FDA-cleared.
Reviewed
Reviewed by Dr. Gene Lee, MD · Board-certified Family Medicine
Every Pepti prescription is reviewed by a licensed U.S. physician before it's dispensed — and only provided if clinically appropriate.
— The process
How it works in Pennsylvania
- 1Complete a free online intake (~5 minutes).
- 2A licensed Pennsylvania physician reviews your case within 24 hours.
- 3Your prescription ships from our FDA-registered compounding pharmacy.
- 4Free shipping arrives 2–4 business days later. Refills ship automatically when your supply runs out — cancel anytime.
— The treatment
What FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) does
FUSION brings together MOTS-c and 5-Amino-1MQ, two peptides studied for metabolism and fat cells, with tesamorelin, studied for belly fat, and BPC-157 for gut repair. A metabolic blend for adults working on weight and energy without a GLP-1, or alongside one. Compounded; not FDA-approved.
— Formulation
— Quality
Every batch independently tested
Every medication batch dispensed through Pepti is independently tested by a qualified third-party laboratory for applicable quality and safety standards before the pharmacy releases it. Batches are tested to the same standard used by 503B outsourcing facilities.
Sterility
USP <71>Confirms the finished preparation is free of viable microorganisms.
Bacterial endotoxins
USP <85>Screens for endotoxins that can cause fever or inflammatory reactions.
Potency
AssayVerifies the labeled concentration of the active peptide is what is in the vial.
Purity
HPLCChecks the active peptide against impurities and degradation products.
Identity
Mass spectrometryConfirms the peptide in the vial is the correct molecule.
pH
USP <791>Confirms the solution sits within the range specified for injection.
Particulate matter
USP <788>Checks the finished vial for visible and sub-visible particles.
Container closure integrity
USP <1207>Confirms the vial seal holds so sterility is maintained through the beyond-use date.
Telemedicine in Pennsylvania
Pennsylvania law permits telemedicine with appropriate physician licensure (Act 6 of 2022). Asynchronous reviews are accepted for non-controlled prescriptions. Pepti is available in all 50 states and Washington, D.C.
Pennsylvania cities Pepti serves
+ 10 more cities
, State College, Norristown, Chester, Bethel Park, Hazleton, Easton, Monroeville, Williamsport, Plum, LebanonWeight management in Pennsylvania
The CDC reports 33.4% (CDC 2023) adult obesity prevalence in Pennsylvania, well above the threshold where GLP-1 therapy demonstrates significant clinical benefit. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is prescribed in Pennsylvania when BMI thresholds and intake criteria are met under physician review.
— Your protocol
How FUSION Blend is prescribed in Pennsylvania.
— Who it's for
- Adults working on weight and energy who want a non-GLP-1 option
- People already on semaglutide or tirzepatide who want metabolic support alongside it
- Anyone whose main complaint is belly fat and sluggish energy
- Patients who want one nightly injection instead of a stack
Your physician decides whether FUSION Blend is appropriate for you after reviewing your intake and labs.
— Directions & duration
Inject 0.25 mL (25 units) subcutaneously once daily Monday through Friday.
— What's included
- Licensed physician review of your intake, history, and labs
- Medication compounded to your prescription by a PCAB-accredited, FDA-registered pharmacy
- Every batch independently tested before release
- Sterile syringes and alcohol prep pads for injectables
- Tracked delivery to your door, refills on schedule
- Message your physician anytime; dose changes without an appointment
— Storage & handling
- Store refrigerated (36–46°F / 2–8°C) at all times, including before first use.
- One vial is your monthly supply. A fresh vial ships to your Pennsylvania address every 28 days on your refill schedule, so you're always well inside the beyond-use date on your label.
- Protect from light. Wipe the stopper with an alcohol pad before every draw.
- Dispose of syringes in the sharps container per the included instructions.
— What to expect
A typical course of FUSION Blend in Pennsylvania.
— The science
How FUSION Blend works, and what the research shows.
— How it works
MOTS-c is studied for switching on the cell's energy sensor and improving how the body handles sugar. 5-Amino-1MQ blocks an enzyme in fat cells that slows their metabolism.
Tesamorelin prompts growth-hormone release and is studied for reducing deep belly fat.
BPC-157 supports the gut lining.
— Clinical evidence
No clinical trial has studied this exact combination.
The evidence is for each peptide on its own, and your physician weighs that when deciding whether the blend fits you.
References
- Lee C, Zeng J, Drew BG et al.. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance · Cell Metab (2015) · PMID 25738459
- Neelakantan H, Vance V, Wetzel MD et al.. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice · Biochem Pharmacol (2018) · PMID 29155147
- Falutz J, Allas S, Blot K et al.. Metabolic effects of a growth hormone-releasing factor in patients with HIV · N Engl J Med (2007) · PMID 18057338
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.

— Pharmacy network accreditation
PCAB-accredited pharmacies on every order.
Every fulfillment runs through a PCAB-accredited pharmacy.
— Common questions
Frequently asked
about FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) in Pennsylvania.
Yes. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is legal when prescribed by a physician licensed in Pennsylvania and dispensed by an FDA-registered compounding pharmacy. Pennsylvania law permits telemedicine with appropriate physician licensure (Act 6 of 2022). Asynchronous reviews are accepted for non-controlled prescriptions.
Most orders ship from our FDA-registered compounding pharmacy within 1–3 business days after physician approval. Delivery within Pennsylvania typically arrives 1-3 business days after shipment. Pepti serves patients across Pennsylvania including Philadelphia, Pittsburgh, Allentown, and Erie.
No. Pepti operates as a fully telehealth platform in Pennsylvania. Pennsylvania law permits telemedicine with appropriate physician licensure (Act 6 of 2022). Asynchronous reviews are accepted for non-controlled prescriptions.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) starts at $279 at Pepti. Pepti is subscription-based — your refill ships when your supply runs out, and you can cancel anytime. Pricing is the same nationwide — no Pennsylvania-specific markup. Shipping is free.
Yes — Pepti is available in all 50 states and Washington, D.C. Wherever you are in the country, a physician licensed in your state reviews your intake and your medication ships from an FDA-registered compounding pharmacy.
You don't need an in-person peptide clinic — Pepti provides doctor-prescribed FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) entirely online anywhere in Pennsylvania. A physician licensed in Pennsylvania reviews your intake, and your medication ships from an FDA-registered compounding pharmacy to your door. Unlike "research use only" peptide sites, every Pepti order requires a valid patient-specific prescription and a licensed dispensing pharmacy.
No. "Research use only" FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is sold with no prescription, no physician, and no dispensing pharmacy, and is not legally sold for human use — independent testing of research-grade peptides has repeatedly found underdosing, mislabeling, and contamination. Prescription FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is compounded for you at an FDA-registered US pharmacy after a licensed physician's review. When comparing FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) options in Pennsylvania, only consider providers that can name their prescribing physicians and their dispensing pharmacy.
The CDC reports an adult obesity prevalence of 33.4% (CDC 2023) in Pennsylvania. GLP-1 therapy is increasingly the standard of care for sustained weight loss in patients with BMI ≥ 30 or BMI ≥ 27 with weight-related comorbidities. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is prescribed in Pennsylvania via Pepti when clinically appropriate.
— More questions32 more questions about Pepti, answered.
Pepti serves all of Pennsylvania. A physician licensed in Pennsylvania reviews every order within 24 hours, the prescription is compounded by a state-licensed, FDA-registered pharmacy, and it ships free and tracked to any Pennsylvania street address. The price is the same as every other state.
Yes. The whole process is online in Pennsylvania: a free assessment, physician review, messaging, dose changes, and refills through your Pepti account or the Hello Pepti app. No clinic visit is required.
Pepti ships FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) to Pennsylvania directly from the pharmacy: free, tracked, unbranded, in insulated packaging with ice packs for refrigerated medication. The pharmacy compounds in 1-3 business days and delivery takes 1-3 business days after shipment. PO Boxes are not accepted.
Every treatment on Pepti's catalog ships to Pennsylvania. Eligibility is confirmed during the assessment from your Pennsylvania shipping address, and if anything ever cannot ship to your address it is refunded.
Yes. Pepti's physicians hold licenses in Pennsylvania, and only a physician licensed where you live reviews and prescribes your order. Their names and credentials are on the providers page.
Yes. Pepti's partner pharmacies are state-licensed, FDA-registered 503A compounding pharmacies licensed to dispense into Pennsylvania, and every batch is independently tested before it ships.
FUSION brings together MOTS-c and 5-Amino-1MQ, two peptides studied for metabolism and fat cells, with tesamorelin, studied for belly fat, and BPC-157 for gut repair. A metabolic blend for adults working on weight and energy without a GLP-1, or alongside one. Compounded; not FDA-approved. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is prescription-only at Pepti: a licensed physician reviews your assessment and, if appropriate, prescribes it to be compounded by a state-licensed, FDA-registered pharmacy.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is commonly prescribed for: Adults working on weight and energy who want a non-GLP-1 option; People already on semaglutide or tirzepatide who want metabolic support alongside it; Anyone whose main complaint is belly fat and sluggish energy; Patients who want one nightly injection instead of a stack. Whether it is appropriate for you is decided by the reviewing physician from your history, medications, and labs where required.
Yes. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is prescription-only. The free online assessment takes about five minutes, a physician licensed in Pennsylvania reviews it within 24 hours, and if approved the prescription goes to the pharmacy. If not approved, the medication charge is refunded.
No. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) can be prescribed from the assessment alone. Bloodwork is required only for the GLP-1s and growth-hormone secretagogues, and the intake tells you if a medication on your order needs it.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.
One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.
Once per fill, $279 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.
The compounded FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.
Reported side effects of FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) are usually mild: mild redness or swelling at injection site; temporary fatigue or headache; mild nausea (uncommon). The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.
Response varies by person, goal, and dose, and FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.
Any dose change is made by your physician from the chart, without an appointment. Message them through your account if you think your dose should change.
Yes. Add FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.
No. Compounded FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is not FDA-approved. It is prepared to your physician's prescription by a state-licensed, FDA-registered 503A pharmacy and every batch is independently tested before release.
Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in Pennsylvania. Research-use-only FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) sold without a prescription is labeled not for human use and is a different product.
MOTS-c is studied for switching on the cell's energy sensor and improving how the body handles sugar. At Pepti it is prescribed to support metabolism support from mots-c, fat-cell enzyme research (5-amino-1mq), studied for belly fat (tesamorelin), gut repair from bpc-157. Individual response varies, and your physician sets expectations at approval.
MOTS-c is studied for switching on the cell's energy sensor and improving how the body handles sugar. 5-Amino-1MQ blocks an enzyme in fat cells that slows their metabolism. Tesamorelin prompts growth-hormone release and is studied for reducing deep belly fat. BPC-157 supports the gut lining. Compounded FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is prescribed for metabolism support from mots-c, fat-cell enzyme research (5-amino-1mq), studied for belly fat (tesamorelin), gut repair from bpc-157. It is commonly requested by adults working on weight and energy who want a non-GLP-1 option; people already on semaglutide or tirzepatide who want metabolic support alongside it; Anyone whose main complaint is belly fat and sluggish energy; patients who want one nightly injection instead of a stack. Whether it is appropriate for you is the reviewing physician's decision.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is studied for metabolism support from mots-c, fat-cell enzyme research (5-amino-1mq), studied for belly fat (tesamorelin), gut repair from bpc-157. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.
No clinical trial has studied this exact combination. The evidence is for each peptide on its own, and your physician weighs that when deciding whether the blend fits you. References are listed on this page.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients. The physician screens for these in your intake, and anything that rules FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) out means it is not prescribed and is refunded.
At Pepti. Complete the free assessment, a physician licensed in Pennsylvania reviews it within 24 hours, and if appropriate FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $279 per month, all-in. Not prescribed means refunded.
Injectable vial: 5 mL, containing 10 mg BPC-157 + 10 mg MOTS-c + 10 mg 5-Amino-1MQ + 15 mg Tesamorelin. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.
Not currently. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 10 other treatments.
$279 per month covers the compounded FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin), the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.
Yes. FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) ships to all 50 states and Washington, D.C, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.
FUSION Blend (BPC-157 / MOTS-c / 5-Amino-1MQ / Tesamorelin) in every state
Pepti is available in all 50 states and Washington, D.C.
Pepti operates in Pennsylvania through licensed physician partnerships. Compounded medications are produced at FDA-registered 503A pharmacies. Treatment decisions are made by your prescribing physician.